-
Healthcare Provider
-
Frequently Ordered Tests
*AmbryScore, a remaining lifetime breast cancer risk estimate, can only be ordered as an addition to this test for eligible patients. Learn MoreFrequently Ordered Tests
Frequently Ordered Tests
Choose a Disease Type
Use AmbryPort
Visit our secure online portal to start your order.
AmbryPort Login
or
Create an AccountOrdering Process
Still unsure about what option to choose? Learn more
Learn about our Re-requisitioning Policy
Click HereWhat Quality Looks Like
Offering anonymous, no-cost genetic testing and confidential genetic counseling to patients suspected of having or clinically diagnosed with hATTR amyloidosis through the hATTR Compass program
Choose an option below to order
your kit and start your genetic testingSelect a Form Type
Excellent Coverage, Personalized Support
Effective November 1st, UnitedHealthcare will require clinicians to sign up for a proprietary portal to order genetic testing for patients covered by their insurance. Learn MorePreverification
Will insurance cover my patient's genetic test?
Click HerePayor Relations
Why partner with us?
Learn MoreOur Resources
Welcome
Please select a menu option
-
- Patient
-
Research
-
Food for Thought: Genetic Testing and the Fight Against Familial Hypercholestero
- Jun 19, 2018
- Blog Post
Increase the Detection of Patients with Hereditary Cancer
- May 15, 2018
- Blog Post
EducateNext: Ambry's CEU Credit Webinars
- May 11, 2018
- Blog Post
-
- Contract Research/Pharma Services
-
About
-
We are driven to give healthcare providers the most advanced testing information available so you can determine the best treatment options for your patients.
-
American Academy of Neurology (AAN)
April 22-28, 2017 - Boston, Massachusetts
Research
Scientific Posters
Poster # 211
Tuesday, April 25, 2017 5:30 - 7:00pm
Jing Wang, Zöe Powis, Amal Yussuf, Jade Tinker, Heather Newman, Tiffiney Carter, Erica Smith, Rhonda Lassiter, Shoji Ichikawa, Negar Ghahramani, Sherry Dadgar, Brigette Tippin Davis, Amanda Bergner. Molecular diagnosis for neurodevelopmental disorders-an overview of multi-gene panels and whole exome sequencing.
Poster # 234
Sunday, April 23, 2017 4:00 - 5:30pm
Amal Yussuf, Zöe Powis, Kirsten Blanco, Jing Wang. Many testing roads can lead to KCNQ2 diagnosis..
Poster # 231
Sunday, April 23, 2017 4:00 - 5:30pm
Zöe Powis, Amal Yussuf, Jing Wang, Heather Newman. Phenotype is not Always a Positive Predictor of Detection Rate in Epilepsy Panels .
Oral Presentations
Session # tbd
Thursday, April 27, 2017 2:25 - 2:35am
Amanda Bergner, Michelle Jackson. Is this Brain Tumor Genetic? Assessment and Evaluation for Hereditary Causes of Primary Brain Tumors.